Impact of Risedronate on Bone Mineral Density and Quality of Life in Postmenopausal Women with Osteoporosis: The Results of 1-Year Follow up
Our objective was to assess the impact of treatment with risedronate on the bone mineral density and quality of life in the women who had postmenopausal osteoporosis (PMO). Sixty-five patients with PMO were included in the study. Forty-five of them were selected randomly, and constituted the study...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2003-06-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://www.turkosteoporozdergisi.org/article_4180/Impact-Of-Risedronate-On-Bone-Mineral-Density-And-Quality-Of-Life-In-Postmenopausal-Women-With-Osteoporosis-The-Results-Of-1-year-Follow-Up |